EUVIMEDEUVIMED entdecken
Crossref

Discovery of potent anticancer and antioxidant agents: design, synthesis, and biological evaluation of thiourea-containing fused thiophene derivatives

Munugala Chandrakanth, Sonam Bisla, Ramesh Mannewar, R. H. Tale, Jesu Arockiaraj, Mukesh Pasupuleti, Janardhan Banothu

New Journal of Chemistry · 2026

DOI: 10.1039/d6nj01651k ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Journal of Chemistry, 2026. Verfasst von Munugala Chandrakanth und 6 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Science and Engineering Research Board.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting VEGFR-2 is a key strategy in anticancer drug development.

Förderung

  • Science and Engineering Research Board

Zitieren

APA

Chandrakanth, M., Bisla, S., Mannewar, R., Tale, R. H., Arockiaraj, J., Pasupuleti, M., & Banothu, J. (2026). Discovery of potent anticancer and antioxidant agents: design, synthesis, and biological evaluation of thiourea-containing fused thiophene derivatives. New Journal of Chemistry. https://doi.org/10.1039/d6nj01651k

Vancouver

Chandrakanth M, Bisla S, Mannewar R, Tale RH, Arockiaraj J, Pasupuleti M, et al. Discovery of potent anticancer and antioxidant agents: design, synthesis, and biological evaluation of thiourea-containing fused thiophene derivatives. New Journal of Chemistry. 2026. doi:10.1039/d6nj01651k

BibTeX
@article{Chandrakanth2026,
  author = {Chandrakanth, Munugala and Bisla, Sonam and Mannewar, Ramesh and Tale, R. H. and Arockiaraj, Jesu and Pasupuleti, Mukesh and Banothu, Janardhan},
  title = {Discovery of potent anticancer and antioxidant agents: design, synthesis, and biological evaluation of thiourea-containing fused thiophene derivatives},
  journal = {New Journal of Chemistry},
  year = {2026},
  doi = {10.1039/d6nj01651k}
}
Kostenlos starten →